Network-based identification of biomarkers coexpressed with multiple pathways.
Unraveling complex molecular interactions and networks and incorporating clinical information in modeling will present a paradigm shift in molecular medicine. Embedding biological relevance via modeling molecular networks and pathways has become increasingly important for biomarker identification in cancer susceptibility and metastasis studies. Here, we give a comprehensive overview of computational methods used for biomarker identification, and provide a performance comparison of several network models used in studies of cancer susceptibility, disease progression, and prognostication. Specifically, we evaluated implication networks, Boolean networks, Bayesian networks, and Pearson's correlation networks in constructing gene coexpression networks for identifying lung cancer diagnostic and prognostic biomarkers. The results show that implication networks, implemented in Genet package, identified sets of biomarkers that generated an accurate prediction of lung cancer risk and metastases; meanwhile, implication networks revealed more biologically relevant molecular interactions than Boolean networks, Bayesian networks, and Pearson's correlation networks when evaluated with MSigDB database.
Mary Babb Randolph Cancer Center/School of Public Health, West Virginia University, Morgantown, WV, USA.
Nancy Lan
NL
Guo
Mary Babb Randolph Cancer Center/School of Public Health, West Virginia University, Morgantown, WV, USA.
Ying-Wooi
YW
Wan
coexpression with signaling pathways; implication networks; lung cancer biomarkers